Danish mushroom inspires cancer researchers

December 8, 2011

Researchers at the University of Copenhagen have explored the active principles of a Danish mushroom and found that some of the substances it contains are particularly toxic towards cancer cells. The goal is to synthesise and refine substances in the mushroom that may be useful in future drug development.

Asia has a long and proud tradition of using folk medicines based on . Many substances found in are today registered as drugs to support chemotherapy treatments for cancer – among others, the mushroom Lentinula edodes (commonly known as Shiitake), which is the primary ingredient in a registered extract on the Japanese market.

"Dr. Ming Chen, a Chinese–Danish physician and specialist in Chinese folk medicine, has discovered a Danish mushroom which contains toxins that are especially effective against . The Faculty of Pharmaceutical Sciences has investigated the mushroom's chemistry and, based on the substances isolated from it, we are developing a refined chemical compound that is even more effective and selective," says Søren Brøgger Christensen, Professor of Natural Products Research at the Faculty of Pharmaceutical Sciences.

The project has received DKK 2.6 million in financial support from Protech Investment Ltd – a spin-off company from a large Chinese producer of natural medicines.

Traditional medicines derived from natural products are often based on the experiences of several generations of shamans. Consequently these inherited experiences are eminent sources of information in the hunt for new active ingredients with potential for drug development. In Denmark, mushrooms have primarily been used in food preparation, while some species have been used as intoxicants. However, they have been largely absent within Danish folk medicine.

This lack of folk knowledge led Dr. Chen, a senior physician at Sønderborg Hospital, to begin screening poisonous Danish mushrooms. After an intense search, he discovered a particular mushroom that is significantly more toxic towards cancer cells than benign human cells. At the Faculty of Pharmaceutical Sciences, exchange student Xuemei Liu, also from China, isolated the active principles:

"This is a completely new class of natural compounds, which makes the research results unique," explains Christensen, who has been collaborating with Chen since 1990, when they were both members of a research group that worked on developing an anti-malaria drug based on an active principle found in Chinese liquorice root.

When an interesting natural substance is discovered, it must go through a development process, in which researchers try to produce new compounds that allow for the proper selectivity in the body and therefore have minimal side effects.

"We were able to isolate the mushroom's active principles and determine their chemical structures. The natural compounds are not useful in themselves because their complex structure means that they cannot be synthesised in a commercially viable manner. The problem with sustainable production of the active substance is further complicated by the fact that tissue of the mushroom – if it is grown from a cell culture – does not produce the active molecule. Therefore, we attempt to produce simple and effective analogues – that is, new compounds that have fine-tuned the effects – so that a simplified molecule carries the same promising properties with regard to combating cancer cells. In this manner we use nature as an inspiration for synthetic chemistry," Christensen explains.

He emphasises that, as with all new drugs, using the results to develop a viable product will be a long, difficult process.

"Even though there is a wealth of medicinal mushrooms on the Asian market, it is unfortunately not possible to transfer Chinese folk medicine directly to Denmark. One problem is that the active principles in are often tested in combination with forms of that we do not use in Europe," Christensen says.

Explore further: Mushroom compound appears to improve effectiveness of cancer drugs

Related Stories

Mushroom compound appears to improve effectiveness of cancer drugs

October 11, 2011
A compound isolated from a wild, poisonous mushroom growing in a Southwest China forest appears to help a cancer killing drug fulfill its promise, researchers report.

Mushroom compound suppresses prostate tumors

May 23, 2011
A mushroom used in Asia for its medicinal benefits has been found to be 100 per cent effective in suppressing prostate tumour development in mice during early trials, new Queensland University of Technology (QUT) research ...

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.